Stock Updates

How has Abbott Laboratories:(NYSE:ABT) performed recently?

Abbott Laboratories (NYSE: ABT) is a large market cap stock with a market cap of 66223.21. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of 34.57, a forward P/E of 18.31 and EPS of 1.3. At a stock price of 45.17 (0.29%) it has a dividend yield of 2.31%.

EPS growth for the last five years have been -10.30%, more recently this last year it has grown by 53.50%. The next year growth is going to be about 11.82% and more long-term 9.36% after five years. EPS growth quarter over quarter is -22.60%. Sales growth for the past five years have been -10.30% and sales growth quarter over quarter is 3.20%.

For performance, Abbott Laboratories the past week has seen a gain of -0.49%. For the last month performance for Abbott Laboratories is 6.53%. While the last quarter is 20.53% and half year, 22.80%. Finally for the year, performance is -7.41%.

The 52-week high for Abbott Laboratories, is at -8.53%, and for the 52-week low it comes to a value of 27.02%. The 20-day simple moving average is 9.85% and 10.12% for the 200-day simple moving average.

Volatility for the week is at 1.01%, and for the month it is 1.28%. Abbott Laboratories, has a target price of 48.

In terms of debt, long term debt/equity is 0.29, and for total debt/equity Abbott Laboratories has 0.41. The gross margin is 56.90%, while operating margin is 14.00%, the profit margin is 11.10%. The current ratio is 1.5 and the quick ratio is 1.2.

Insider ownership is at 0.30%, with instituitional ownership at 71.30%. Abbott Laboratories has a payout ratio of 66.50%. With the total shares outstanding coming to 1470.32. The shares float is 1465.05, with the float short at 4.76%, with short ratio coming to 6.89.

In terms of returns, the return on assets see Abbott Laboratories, get 5.60%, with its returns on investment at 7.70%. Return on equity is 10.90%. So will the investors see the target price of 48, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment